SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-017648
Filing Date
2024-05-20
Accepted
2024-05-20 16:07:13
Documents
19
Period of Report
2024-05-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K crvo20240520_8k.htm   iXBRL 8-K 41918
2 EXHIBIT 10.1 ex_676777.htm EX-10.1 110834
3 EXHIBIT 10.2 ex_676778.htm EX-10.2 37499
4 EXHIBIT 10.3 ex_676779.htm EX-10.3 23507
5 EXHIBIT 99.1 ex_676746.htm EX-99.1 10485
10 image01.jpg GRAPHIC 12766
  Complete submission text file 0001437749-24-017648.txt   427531

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA crvo-20240517.xsd EX-101.SCH 3409
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20240517_def.xml EX-101.DEF 11424
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20240517_lab.xml EX-101.LAB 15310
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20240517_pre.xml EX-101.PRE 11584
22 EXTRACTED XBRL INSTANCE DOCUMENT crvo20240520_8k_htm.xml XML 2808
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 24964441
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)